ELOX — ELOXX PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 22 SEC-registered investment managers reported holding ELOX (ELOXX PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $34.70M across 2.50M shares. Ownership is concentrated: the five largest holders account for 80.0% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 22 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ELOXX PHARMACEUTICALS INC (ELOX) include Siren, L.L.C., Aberdeen Group plc, Nantahala Capital Management, LLC, ranked by reported 13F value among the 42 institutional holders on this page.
ELOX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 15 | 1.90M | $29.09M | +11.3% |
| Q2 2026 | 22 | 2.50M | $34.70M | — |
| Q2 2024 | 1 | 62 | $43 | +0.0% |
| Q1 2024 | 1 | 62 | $62 | — |
| Q4 2023 | 4 | 91.02K | $108.99K | +0.0% |
| Q3 2023 | 17 | 512.01K | $2.46M | -1.3% |
| Q2 2023 | 5 | 42.19K | $164.13K | +0.0% |
| Q1 2023 | 7 | 43.01K | $107.96K | -32.7% |
Over the 8 quarters shown, institutional share counts increased 4317% in aggregate (Q1 2023 → Q3 2026); the largest single-quarter swing was Q1 2023 (-32.7%).
Top Institutional Holders (Q3 2026) — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $6.12M | 0.14% | Hold | |
| 400.00K | $6.12M | 0.01% | Hold | |
| 400.00K | $6.12M | 0.28% | Hold | |
| 381.98K | $5.85M | 4.49% | Reduce | |
| 202.63K | $3.10M | 0.00% | Add | |
| 78.68K | $1.20M | 0.00% | Hold | |
| 19.95K | $305.37K | 0.00% | New | |
| 13.67K | $209.27K | 0.00% | Add | |
| 2.03K | $31.02K | 0.00% | Add | |
| 718 | $10.99K | 0.00% | Hold | |
| 96 | $1.47K | 0.00% | Hold | |
| 25 | $383 | 0.00% | Hold | |
| 5 | $77 | 0.00% | Hold | |
| 4 | $61 | 0.00% | Hold | |
| 2 | $31 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $5.55M | 0.01% | New | |
| 400.00K | $5.55M | 0.28% | New | |
| 400.00K | $5.55M | 0.22% | New | |
| 400.00K | $5.55M | 0.46% | New | |
| 400.00K | $5.55M | 0.11% | New | |
| 397.16K | $5.51M | 3.64% | New | |
| 78.68K | $1.09M | 0.00% | New | |
| 10.60K | $147.16K | 0.00% | New | |
| 10.00K | $138.80K | 0.01% | New | |
| 1.54K | $21.43K | 0.00% | New | |
| 718 | $9.97K | 0.00% | New | |
| 637 | $8.84K | 0.00% | New | |
| 126 | $1.75K | 0.00% | New | |
| 96 | $1.33K | 0.00% | New | |
| 98 | $1.00K | 0.00% | New | |
| 25 | $347 | 0.00% | New | |
| 12 | $167 | 0.00% | New | |
| 5 | $69 | 0.00% | New | |
| 4 | $56 | 0.00% | New | |
| 4 | $56 | 0.00% | New | |
| 2 | $28 | 0.00% | New | |
| 1 | $14 | 0.00% | New |
Q2 2024 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 62 | $43 | 0.00% | Hold |
Q1 2024 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 62 | $62 | 0.00% | New |
Q4 2023 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 52.35K | $62.83K | 0.00% | Hold | |
| 25.12K | $30.15K | 0.00% | Hold | |
| 13.53K | $16.00K | 0.00% | Hold | |
| 15 | $18 | 0.00% | Hold |
Q3 2023 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 275.00K | $1.32M | 0.02% | New | |
| 54.08K | $260.10K | 0.10% | New | |
| 52.35K | $251.83K | 0.00% | New | |
| 37.00K | $178.00K | 0.07% | New | |
| 25.12K | $120.84K | 0.01% | New | |
| 20.79K | $99.98K | 0.00% | Hold | |
| 19.59K | $93.26K | 0.00% | Reduce | |
| 13.53K | $65.00K | 0.00% | New | |
| 10.64K | $51.17K | 0.01% | New | |
| 1.83K | $8.80K | 0.00% | New | |
| 1.17K | $5.64K | 0.00% | Hold | |
| 526 | $3.00K | 0.00% | New | |
| 291 | $1.40K | 0.00% | New | |
| 79 | $380 | 0.00% | Hold | |
| 15 | $72 | 0.00% | New | |
| 4 | $19 | 0.00% | New | |
| 1 | $5 | 0.00% | Hold |
New Positions (Q2 2026)
- Aberdeen Group plc 400.00K sh · $5.55M
- EcoR1 Capital, LLC 400.00K sh · $5.55M
- Nantahala Capital Management, LLC 400.00K sh · $5.55M
- Samsara BioCapital, LLC 400.00K sh · $5.55M
- Siren, L.L.C. 400.00K sh · $5.55M
- Stonepine Capital Management, LLC 397.16K sh · $5.51M
- VANGUARD CAPITAL MANAGEMENT LLC 78.68K sh · $1.09M
- VANGUARD FIDUCIARY TRUST CO 10.60K sh · $147.16K
- SEVEN GRAND MANAGERS, LLC 10.00K sh · $138.80K
- Morgan Stanley 1.54K sh · $21.43K
- Vanguard Global Advisers, LLC 718 sh · $9.97K
- UBS Group AG 637 sh · $8.84K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 400.00K | 400.00K | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 400.00K | 400.00K | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 400.00K | 400.00K | — | — | — | — | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 381.98K | 397.16K | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 202.63K | 1.54K | — | — | — | 79 | 79 | 79 | 80 | 3.18K | 3.18K | 5.63K | 3.69K |
| VANGUARD CAPITAL MANAGEMENT LLC | 78.68K | 78.68K | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 19.95K | — | — | — | — | 19.59K | 20.26K | 20.24K | 20.20K | 807.68K | 802.41K | 800.33K | 798.06K |
| VANGUARD FIDUCIARY TRUST CO | 13.67K | 10.60K | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 2.03K | 637 | — | — | — | 291 | — | 469 | 123 | — | — | 21.85K | — |
| Vanguard Global Advisers, LLC | 718 | 718 | — | — | — | — | — | — | — | — | — | — | — |
| Pioneer Family Office, LLC | 96 | 96 | — | — | — | — | — | — | — | — | — | — | — |
| Altshuler Shaham Ltd | 25 | 25 | — | — | 25.12K | 25.12K | — | — | — | — | — | — | — |
| Towne Trust Company, N.A | 5 | 5 | 62 | 62 | — | — | — | — | — | — | — | — | — |
| Activest Wealth Management | 4 | 4 | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — |
| EcoR1 Capital, LLC | — | 400.00K | — | — | — | — | — | — | — | — | — | — | — |
| Samsara BioCapital, LLC | — | 400.00K | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | 275.00K | — | — | — | — | — | — | — |
| SILVERARC CAPITAL MANAGEMENT, LLC | — | — | — | — | — | 54.08K | — | — | — | — | — | — | — |
| MENORA MIVTACHIM HOLDINGS LTD. | — | — | — | — | 52.35K | 52.35K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ELOX?
As of 2026-Q2, 22 institutional funds reported holding ELOX (ELOXX PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $34.70M.
How many shares of ELOX do institutions own?
13F filers reported 2.50M shares of ELOX, worth $34.70M in aggregate at the end of 2026-Q2.
Is institutional ownership of ELOX rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of ELOX?
The largest 13F holders are Siren, L.L.C., Aberdeen Group plc, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, EcoR1 Capital, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ELOXX PHARMACEUTICALS INC?
The major shareholders of ELOXX PHARMACEUTICALS INC (ELOX) by reported 13F value are Siren, L.L.C., Aberdeen Group plc, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, EcoR1 Capital, LLC, among 42 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.